Drosophila melanogaster as a model organism for Alzheimer's disease

K Prüßing, A Voigt, JB Schulz - Molecular neurodegeneration, 2013 - Springer
Drosophila melanogaster provides an important resource for in vivo modifier screens of
neurodegenerative diseases. To study the underlying pathogenesis of Alzheimer's disease …

Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases

N Rani, MM Alam, A Jamal, UB Ghaffar… - Ageing Research Reviews, 2023 - Elsevier
Neurodegenerative diseases (NDs) are a heterogeneous group of aging-associated
ailments characterized by interrupting cellular proteostasic machinery and the misfolding of …

Modeling Alzheimer's Disease in Caenorhabditis elegans

J Alvarez, P Alvarez-Illera, J Santo-Domingo… - Biomedicines, 2022 - mdpi.com
Alzheimer's disease (AD) is the most frequent cause of dementia. After decades of research,
we know the importance of the accumulation of protein aggregates such as β-amyloid …

Connecting the dots between tau dysfunction and neurodegeneration

B Frost, J Götz, MB Feany - Trends in cell biology, 2015 - cell.com
Tauopathies are devastating and ultimately fatal neurodegenerative diseases, which are
histopathologically defined by insoluble filamentous deposits of abnormally phosphorylated …

Drosophila as a Model to Study the Relationship Between Sleep, Plasticity, and Memory

S Dissel - Frontiers in physiology, 2020 - frontiersin.org
Humans spend nearly a third of their life sleeping, yet, despite decades of research the
function of sleep still remains a mystery. Sleep has been linked with various biological …

Discovery of a new donepezil-like acetylcholinesterase inhibitor for targeting Alzheimer's disease: computational studies with biological validation

BA Akhoon, S Choudhary, H Tiwari… - Journal of Chemical …, 2020 - ACS Publications
Alzheimer's disorder is one of the most common worldwide health problems, and its
prevalence continues to increase, thereby straining the healthcare budgets of both …

Synaptic abnormalities in a Drosophila model of Alzheimer's disease

SD Mhatre, V Satyasi, M Killen… - Disease models & …, 2014 - journals.biologists.com
Alzheimer's disease (AD) is an age-related neurodegenerative disease characterized by
memory loss and decreased synaptic function. Advances in transgenic animal models of AD …

Identification of a novel Wnt antagonist based therapeutic and diagnostic target for Alzheimer's disease using a stem cell-derived model

M Patil, N Gamit, A Dharmarajan, G Sethi, S Warrier - Bioengineering, 2023 - mdpi.com
Currently, all the existing treatments for Alzheimer's disease (AD) fail to stall progression due
to longer duration of time between onset of the symptoms and diagnosis of the disease …

[HTML][HTML] Enhanced sleep reverses memory deficits and underlying pathology in Drosophila models of Alzheimer's disease

S Dissel, M Klose, J Donlea, L Cao, D English… - Neurobiology of sleep …, 2017 - Elsevier
To test the hypothesis that sleep can reverse cognitive impairment during Alzheimer's
disease, we enhanced sleep in flies either co-expressing human amyloid precursor protein …

Dopamine, sleep, and neuronal excitability modulate amyloid-β–mediated forgetting in Drosophila

JC Kaldun, SR Lone, AM Humbert Camps… - PLoS …, 2021 - journals.plos.org
Alzheimer disease (AD) is one of the main causes of age-related dementia and
neurodegeneration. However, the onset of the disease and the mechanisms causing …